Earnings Analyzer
Stock earnings page

PROMIS NEUROSCIENCES INCORPORATED (PMN)

Track the next or latest earnings date for PROMIS NEUROSCIENCES INCORPORATED, review consensus estimates, and see cached AI analysis for recent quarterly results.

Recent earnings news

Philip Morris International Inc (PM) Stock Down 3.2% but Still Overvalued -- GF Score: 87/100
www.gurufocus.com · 2026-07-30T21:11:59

On July 30, 2026, Philip Morris International Inc (PM) shares fell 3.2% to a current price of $192.00, within a 52-week range of $142.11 to $207.76. The recent

MP Materials Corp. (MP) Earnings Expected to Grow: Should You Buy?
finance.yahoo.com · 2026-07-30T14:00:10

MP Materials (MP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ProMIS Neurosciences (PMN) Shares Rally on Promising Alzheimer's Trial Data
www.gurufocus.com · 2026-07-28T18:57:41

Calendar & Research Financial Calendar Earnings Calendar & Reports Analyst Ratings Fund Letters Archive Transcripts Search Stock Market Holidays ... On July 28, 2026, ProMIS Neurosciences Inc (NASDAQ: PMN) saw a notable increase in its stock price following the release of encouraging interim ...

Chardan raises ProMIS Neurosciences stock price target on trial data By Investing.com
ca.investing.com · 2026-07-28T15:08:10

Core Scientific Inc (CORZ) Q2 2026 Earnings Call Highlights: Strategic Partnerships and Robust ... Seagate tops quarterly estimates and issues blockbuster first-quarter guidance ... Investing.com - Chardan raised its price target on ProMIS Neurosciences (NASDAQ:PMN) to $33 from $20 while maintaining…

Why is ProMIS Neurosciences stock surging today? By Investing.com
ca.investing.com · 2026-07-28T13:20:16

Investing.com -- ProMIS Neurosciences stock surged 16.1% in pre-open trading after the clinical-stage biopharmaceutical company unveiled blinded six-month interim safety and biomarker results from its PRECISE-AD Phase 1b trial of PMN310, its lead Alzheimer’s disease candidate, during a live ...

Upcoming earnings date

Aug 12, 2026

Time not specified

Fiscal quarter: 2026-06-30

EPS estimate: -$1.45

Revenue estimate: N/A

Market cap: $133.80M

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week
Date Quarter Report window EPS est. Revenue est.
Aug 12, 2026 2026-06-30 Time not specified -$1.45 N/A